19-8302380-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016579.4(CD320):c.*83C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,551,686 control chromosomes in the GnomAD database, including 1,430 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 175 hom., cov: 33)
Exomes 𝑓: 0.011 ( 1255 hom. )
Consequence
CD320
NM_016579.4 3_prime_UTR
NM_016579.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.280
Genes affected
CD320 (HGNC:16692): (CD320 molecule) This gene encodes the transcobalamin receptor that is expressed at the cell surface. It mediates the cellular uptake of transcobalamin bound cobalamin (vitamin B12), and is involved in B-cell proliferation and immunoglobulin secretion. Mutations in this gene are associated with methylmalonic aciduria. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-8302380-G-C is Benign according to our data. Variant chr19-8302380-G-C is described in ClinVar as [Benign]. Clinvar id is 1249046.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.164 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD320 | NM_016579.4 | c.*83C>G | 3_prime_UTR_variant | 5/5 | ENST00000301458.10 | NP_057663.1 | ||
CD320 | NM_001165895.2 | c.*83C>G | 3_prime_UTR_variant | 4/4 | NP_001159367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD320 | ENST00000301458.10 | c.*83C>G | 3_prime_UTR_variant | 5/5 | 1 | NM_016579.4 | ENSP00000301458 | P1 | ||
CD320 | ENST00000596002.5 | c.*1220C>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ENSP00000471773 | ||||
CD320 | ENST00000537716.6 | c.*83C>G | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000437697 | ||||
CD320 | ENST00000599573.1 | c.*532C>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 2 | ENSP00000471551 |
Frequencies
GnomAD3 genomes AF: 0.0223 AC: 3395AN: 152140Hom.: 174 Cov.: 33
GnomAD3 genomes
AF:
AC:
3395
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0234 AC: 5795AN: 248054Hom.: 421 AF XY: 0.0291 AC XY: 3910AN XY: 134504
GnomAD3 exomes
AF:
AC:
5795
AN:
248054
Hom.:
AF XY:
AC XY:
3910
AN XY:
134504
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0115 AC: 16053AN: 1399428Hom.: 1255 Cov.: 25 AF XY: 0.0157 AC XY: 10957AN XY: 699528
GnomAD4 exome
AF:
AC:
16053
AN:
1399428
Hom.:
Cov.:
25
AF XY:
AC XY:
10957
AN XY:
699528
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0223 AC: 3401AN: 152258Hom.: 175 Cov.: 33 AF XY: 0.0243 AC XY: 1808AN XY: 74446
GnomAD4 genome
AF:
AC:
3401
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
1808
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
276
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 25, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at